Prefrontal dopamine D1 receptors and working memory in schizotypal personality disorder: a PET study with [11C]NNC112

被引:20
|
作者
Thompson, Judy L. [1 ,5 ]
Rosell, Daniel R. [2 ,3 ]
Slifstein, Mark [1 ]
Girgis, Ragy R. [1 ]
Xu, Xiaoyan [1 ]
Ehrlich, Yosefa [2 ,3 ]
Kegeles, Lawrence S. [1 ,4 ]
Hazlett, Erin A. [2 ,3 ]
Abi-Dargham, Anissa [1 ,4 ]
Siever, Larry J. [2 ,3 ]
机构
[1] Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA
[2] Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA
[3] James J Peters Vet Affairs Med Ctr, Bronx, NY 10468 USA
[4] Columbia Univ Coll Phys & Surg, Dept Radiol, New York, NY 10032 USA
[5] Rutgers State Univ, Sch Hlth Related Profess, Scotch Plains, NJ 07076 USA
关键词
Schizotypal personality disorder; Schizophrenia; PET; Dopamine; Prefrontal cortex; Working memory; IN-VIVO BINDING; NEUROPSYCHOLOGICAL PERFORMANCE; SCHIZOPHRENIA SPECTRUM; NAIVE PATIENTS; D-1; RECEPTORS; TASK; SPECIFICITY; SELECTIVITY; TOMOGRAPHY; IMPAIRMENT;
D O I
10.1007/s00213-014-3566-6
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Schizotypal personality disorder (SPD) is associated with working memory (WM) impairments that are similar to those observed in schizophrenia. Imaging studies have suggested that schizophrenia is associated with alterations in dopamine D1 receptor availability in the prefrontal cortex (PFC) that may be related to the WM impairments that characterize this disorder. The aim of this study was to characterize prefrontal D1 receptor availability and its relation to WM performance in SPD. We used positron emission tomography (PET) and the radiotracer [C-11]NNC112 with 18 unmedicated SPD and 21 healthy control participants; as an index of D1 receptor availability, binding potential (BP) measures (BPF, BPND, and BPP) were calculated for prefrontal and striatal subregions. To assess WM, SPD participants completed the 2-back and Paced Auditory Serial Addition Test (PASAT). There were no significant group differences in PFC BP. BPF and BPP in the medial PFC were significantly negatively related to PASAT performance (r (s) = -0.551, p = .022 and r (s) = -0.488, p = .047, respectively), but BP was not related to 2-back performance. In contrast to what has been found in schizophrenia, SPD was not associated with significant alterations in prefrontal D1 receptor availability. Similar to previous schizophrenia findings, however, higher prefrontal D1 receptor availability was associated with poorer WM performance (as measured by the PASAT) in SPD. These findings suggest that schizophrenia and SPD may share a common pathophysiological feature related to prefrontal dopamine functioning that contributes to WM dysfunction, but that in SPD, alterations in D1 may occur only in a subset of individuals and/or to an extent that is minor relative to what occurs in schizophrenia.
引用
收藏
页码:4231 / 4240
页数:10
相关论文
共 50 条
  • [21] Supranormal stimulation of D-1 dopamine receptors in the rodent prefrontal cortex impairs spatial working memory performance
    Zahrt, J
    Taylor, JR
    Mathew, RG
    Arnsten, AFT
    JOURNAL OF NEUROSCIENCE, 1997, 17 (21) : 8528 - 8535
  • [22] PET STUDIES ON DOPAMINE D1 RECEPTORS IN THE HUMAN BRAIN WITH CARBON-11-SCH-39166 AND CARBON-11-NNC-756
    LAIHINEN, AO
    RINNE, JO
    RUOTTINEN, HM
    NAGREN, KA
    LEHIKOINEN, PK
    OIKONEN, VJ
    RUOTSALAINEN, UH
    RINNE, UK
    JOURNAL OF NUCLEAR MEDICINE, 1994, 35 (12) : 1916 - 1920
  • [23] Occupancy of Dopamine D2 and D3 Receptors by Buspirone: A [11C]-(+)-PHNO PET Study in Humans
    Le Foll, Bernard
    Payer, Doris
    Di Ciano, Patricia
    Guranda, Mihail
    Nakajima, Shinichiro
    Tong, Junchao
    Mansouri, Esmaeil
    Wilson, Alan
    Houle, Sylvain
    Meyer, Jeff
    Graff, Ariel
    Boileau, Isabelle
    BIOLOGICAL PSYCHIATRY, 2015, 77 (09) : 94S - 94S
  • [24] Exploring regulation and function of dopamine D3 receptors in alcohol use disorder. A PET [11C]-(+)-PHNO study
    Chukwueke, Chidera C.
    Nona, Christina N.
    McPhee, Matthew D.
    Mansouri, Esmaeil
    Rubin-Kahana, Dafna S.
    Martinez, Diana
    Boileau, Isabelle
    Hendershot, Christian S.
    Le Foll, Bernard
    NEUROPSYCHOPHARMACOLOGY, 2021, 46 (12) : 2112 - 2120
  • [25] Whole-body biodistribution and estimation of radiation-absorbed doses of the dopamine D1 receptor radioligand 11C-NNC 112 in humans
    Cropley, VL
    Fujita, M
    Musachio, JL
    Hong, J
    Ghose, S
    Sangare, J
    Nathan, PJ
    Pike, VW
    Innis, RB
    JOURNAL OF NUCLEAR MEDICINE, 2006, 47 (01) : 100 - 104
  • [26] Age-dependent decline of dopamine D1 receptors in human brain: A PET study
    Wang, Y
    Chan, GLY
    Holden, JE
    Dobko, T
    Mak, E
    Schulzer, M
    Huser, JM
    Snow, BJ
    Ruth, TJ
    Calne, DB
    Stoessl, AJ
    SYNAPSE, 1998, 30 (01) : 56 - 61
  • [27] [11C]cyclopropyl-FLB 457:: A PET radioligand for low densities of dopamine D2 receptors
    Airaksinen, Anu J.
    Nag, Sangram
    Finnema, Sjoerd J.
    Mukherjee, Jogeshwar
    Chattopadhyay, Sankha
    Gulyas, Balazs
    Farde, Lars
    Halldin, Christer
    BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (13) : 6467 - 6473
  • [28] Differential Effects of Stress on [11C]Raclopride and [11C] MNPA Binding to Striatal D2/D3 Dopamine Receptors: A PET Study in Conscious Monkeys
    Tsukada, Hideo
    Ohba, Hiroyuki
    Nishiyama, Shingo
    Kakiuchi, Takeharu
    SYNAPSE, 2011, 65 (01) : 84 - 89
  • [29] Investigating the effects of norepinephrine 1 receptor blockade on dopamine levels: A pilot PET study with [11C]-(+)-PHNO in controls
    Le Foll, Bernard
    Thiruchselvam, Thulasi
    Lu, Shawna Xiaoyun
    Mohammed, Shakira
    Mansouri, Esmaeil
    Lagzdins, Dina
    Nakajima, Shinichiro
    Wilson, Alan A.
    Graff-Guerrero, Ariel
    Di Ciano, Patricia
    Boileau, Isabelle
    SYNAPSE, 2017, 71 (07)
  • [30] Chronic subthalamic nucleus stimulation and striatal D2 dopamine receptors in Parkinson's disease -: A [11C]-raclopride PET study
    Thobois, S
    Fraix, V
    Savasta, M
    Costes, N
    Pollak, P
    Mertens, P
    Koudsie, A
    Le Bars, D
    Benabid, AL
    Broussolle, E
    JOURNAL OF NEUROLOGY, 2003, 250 (10) : 1219 - 1223